Clinical trial on improving the diagnosis and treatment of cerebral aneurysms based on multi-center hospitals and big data in China

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800019492

Enrollment

Unknown

Registered

2018-11-14

Start date

2019-03-01

Completion date

Unknown

Last updated

2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral aneurysm

Interventions

clipping group:Craniotomy aneurysm clipping

coiling group:Interventional embolization

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The exact imaging (CTA, MRA, DSA) evidence is clearly diagnosed as a ruptured or unruptured cystic cerebral aneurysm; 2. Patients and their families' hospitals participate in this study and can follow long-term follow-up; 3. The patient and the patient's family signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. traumatic aneurysm; 2. non-cystic aneurysm; 3. combined with other diseases such as polycystic kidney disease, equine syndrome, Ehlers-Danlos syndrome, known intracranial lesions such as tumor, cerebral vascular malformation, moyamoya disease, psychosis Or a history of neurological diseases; 4. combined with other malignant diseases such as lung cancer, gastric cancer or expected survival time of patients less than 1 year; 5. patients can not be long-term follow-up; 6. have participated in other research cohorts of the same category.

Design outcomes

Primary

Measure	Time frame
Modified Rainkin Scale (mRS);	—

Countries

China

Contacts

Public ContactXinyu Yang

Tianjin Medical University General Hospital

yangxinyu@tmu.edu.cn+86 18622766038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026